简介：latest alerts to consumers and health care providers warning of recently identified adverse effects associated with currently available drugs and supplements.

原站：http://www.drugs.com/fda_alerts.html

“Drugs.com - FDA MedWatch Alerts”的内容更新

累计：240 篇（自 2008-07-17 起）

更新：约1篇/周，最后更新165 天前

Drugs.com - FDA MedWatch Alerts

Saphris (asenapine maleate): Drug Safety Communicati

audience: psychiatry, patients [posted 09/01/2011]issue: fda notified healthcare professionals and patients that serious allergic reactions have been reported with the use of saphris (asenapine maleate). the contraindications, warnings and... ... (165 天前)

http://inezha.com/w/72mqvu8d

Drugs.com - FDA MedWatch Alerts

Reclast (zoledronic acid): Drug Safety Communication

audience: endocrinology, pharmacy, patient [posted 09/01/2011]issue: fda notified healthcare professionals and patients of an update to the drug label for reclast (zoledronic acid) regarding the risk of kidney failure. cases of acute renal... ... (165 天前)

http://inezha.com/w/sewbpu86

Drugs.com - FDA MedWatch Alerts

H & P Industries Povidone Iodine Swabsticks, Prep So

audience: pharmacy, consumer, risk manager multiple brands affected - listed below[posted 08/26/2011]issue: h & p industries and fda notified health professionals and the public of a recall of all lots (lots beginning with 8j-8m,... ... (171 天前)

http://inezha.com/w/wddfs58u

Drugs.com - FDA MedWatch Alerts

Celexa (citalopram hydrobromide): Drug Safety Commun

audience: psychiatry, cardiology issue: fda notified healthcare professionals and patients that the antidepressant celexa (citalopram hydrobromide) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in... ... (173 天前)

http://inezha.com/w/lfmdf58t

Drugs.com - FDA MedWatch Alerts

Vasopressin Injection USP, Multiple Dose Vials: Reca

audience: risk manager, pharmacy issue: american regent, inc. is conducting a nationwide voluntary recall of multiple lots of vasopressin injection, usp to the retail/hospital level. this product recall was initiated by american regent, inc. because... ... (193 天前)

http://inezha.com/w/k7w1k58q

Drugs.com - FDA MedWatch Alerts

Recombinant Human Growth Hormone (somatropin): Ongoi

audience: pediatrics, endocrinology [updated 08/04/2011] fda has determined that, at this time, the evidence regarding recombinant human growth hormone and increased risk of death is inconclusive. in its analysis of the saghe study, fda... ... (193 天前)

http://inezha.com/w/dcd2458l

Drugs.com - FDA MedWatch Alerts

Diflucan (fluconazole): Drug Safety Communication -

audience: obgyn, pharmacy, infectious disease issue: fda is informing the public that treatment with chronic, high doses (400-800mg/day) of diflucan (fluconazole) during the first trimester of pregnancy may be associated with a rare and distinct set... ... (194 天前)

http://inezha.com/w/ikmtv58p

订阅者 ( 2 )

相关订阅源